Patients treated with bivalirudin still at higher risk of stent thrombosis: a comprehensive meta-analysis of randomized clinical trials of bivalirudin and heparin for percutaneous coronary interventions

scientific article published on 19 January 2018

Patients treated with bivalirudin still at higher risk of stent thrombosis: a comprehensive meta-analysis of randomized clinical trials of bivalirudin and heparin for percutaneous coronary interventions is …
instance of (P31):
meta-analysisQ815382
scholarly articleQ13442814

External links are
P356DOI10.5603/KP.A2018.0024
P698PubMed publication ID29350380

P50authorJarosław HiczkiewiczQ110727107
Marek GrygierQ110727113
Adrian GwizdałaQ114739778
Maciej LesiakQ55392921
Stefan GrajekQ56255633
Aleksander AraszkiewiczQ88853117
P2093author name stringMichał Michlak
P921main subjectthrombosisQ261327
bivalirudinQ4919218
P577publication date2018-01-19
P1433published inKardiologia PolskaQ2775982
P1476titlePatients treated with bivalirudin still at higher risk of stent thrombosis: a comprehensive meta-analysis of randomized clinical trials of bivalirudin and heparin for percutaneous coronary interventions

Search more.